ELL 抗体 (PE)
Quick Overview for ELL 抗体 (PE) (ABIN2173820)
抗原
See all ELL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human ELL
-
亚型
- IgG
-
-
anti-Elongation Factor RNA Polymerase II (ELL) (Internal Region) antibody
ELL 适用: 人, 小鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 551-600) antibodyELL 适用: 人, 小鼠, 犬, 大鼠, Cow, 马, 斑马鱼, 猴 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL 适用: 人, 猴 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) antibodyELL 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 522-619) antibodyELL 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 431-480) antibodyELL 适用: 人, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 350-450) antibodyELL 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (Middle Region) antibodyELL 适用: 人, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL 适用: 人, 小鼠, 犬, 大鼠, Cow, 豚鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (C-Term) antibodyELL 适用: 人, 小鼠, 犬, 大鼠, Cow, 马, 豚鼠, 斑马鱼 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
说明
-
Exitation/Emission: 480,565nm/578nm
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at 4 °C for 12 months.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
别名
- ELL
-
背景
-
Eukaryotic RNA polymerase II mediates the synthesis of mature and functional messenger RNA. This is a multistep process, called the transcription cycle, that includes five stages: preinitiation, promoter, clearance, elongation and termination. Elongation is thought to be a critical stage for the regulation of gene expression. ELL (11-19 lysine-rich leukemia protein), also designated MEN, functions as an RNA polymerase II elongation factor that increases the rate of transcription by suppressing transient pausing by RNA polymerase II. It is also thought to regulate cellular proliferation. ELL is abundantly expressed in peripheral blood leukocytes, skeletal muscle, placenta and testis, with lower expression in spleen, thymus, heart, brain, lung, kidney, liver and ovary. The gene encoding human ELL, which maps to chromosome 19p13.1, is one of several genes that undergo translocation with the MLL gene on chromosome 11q23 in acute myeloid leukemia. MLL (myeloid/lymphoid leukemia, also designated ALL-1 and HRX) regulates embryonal and hematopoietic development.
Synonyms: ELL_HUMAN, Eleven nineteen lysine rich leukemia gene, Eleven-nineteen lysine-rich leukemia protein, ELL1, elongation factor RNA polymerase II, Men, RNA polymerase II elongation factor, RNA polymerase II elongation factor ELL. -
基因ID
- 8178
抗原
-
